1
|
Yu CT, Kandoi S, Periasamy R, Reddy LVK, Follett HM, Summerfelt P, Martinez C, Guillaume C, Bowie O, Connor TB, Lipinski DM, Allen KP, Merriman DK, Carroll J, Lamba DA. Human iPSC-derived photoreceptor transplantation in the cone dominant 13-lined ground squirrel. Stem Cell Reports 2024; 19:331-342. [PMID: 38335965 PMCID: PMC10937153 DOI: 10.1016/j.stemcr.2024.01.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2023] [Revised: 01/11/2024] [Accepted: 01/12/2024] [Indexed: 02/12/2024] Open
Abstract
Several retinal degenerations affect the human central retina, which is primarily comprised of cones and is essential for high acuity and color vision. Transplanting cone photoreceptors is a promising strategy to replace degenerated cones in this region. Although this approach has been investigated in a handful of animal models, commonly used rodent models lack a cone-rich region and larger models can be expensive and inaccessible, impeding the translation of therapies. Here, we transplanted dissociated GFP-expressing photoreceptors from retinal organoids differentiated from human induced pluripotent stem cells into the subretinal space of damaged and undamaged cone-dominant 13-lined ground squirrel eyes. Transplanted cell survival was documented via noninvasive high-resolution imaging and immunohistochemistry to confirm the presence of human donor photoreceptors for up to 4 months posttransplantation. These results demonstrate the utility of a cone-dominant rodent model for advancing the clinical translation of cell replacement therapies.
Collapse
Affiliation(s)
- Ching Tzu Yu
- Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA
| | - Sangeetha Kandoi
- Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, CA, USA
| | - Ramesh Periasamy
- Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, WI, USA
| | - L Vinod K Reddy
- Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, CA, USA
| | - Hannah M Follett
- Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA
| | - Phyllis Summerfelt
- Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, WI, USA
| | - Cassandra Martinez
- Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, CA, USA
| | - Chloe Guillaume
- Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, WI, USA; School of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
| | - Owen Bowie
- School of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
| | - Thomas B Connor
- Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, WI, USA
| | - Daniel M Lipinski
- Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA; Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, WI, USA
| | - Kenneth P Allen
- Department of Microbiology and Immunology, Biomedical Resource Center, Medical College of Wisconsin, Milwaukee, WI, USA
| | - Dana K Merriman
- Department of Biology, University of Wisconsin-Oshkosh, Oshkosh, WI, USA
| | - Joseph Carroll
- Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA; Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, WI, USA
| | - Deepak A Lamba
- Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, CA, USA.
| |
Collapse
|
2
|
Hu K, Lv L, Huang H, Yin G, Gao J, Liu J, Yang Y, Zeng W, Chen Y, Zhang N, Zhang F, Ma Y, Chen F. A Novel Tree Shrew Model of Chronic Experimental Autoimmune Uveitis and Its Disruptive Application. Front Immunol 2022; 13:889596. [PMID: 35711454 PMCID: PMC9196886 DOI: 10.3389/fimmu.2022.889596] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2022] [Accepted: 04/29/2022] [Indexed: 11/27/2022] Open
Abstract
Background Previous studies have established several animal models for experimental autoimmune uveitis (EAU) in rodents without the fovea centralis in the human retina. This study aimed to develop and explore the application of a novel EAU model in tree shrews with a cone-dominated retina resembling the human fovea. Methods Tree shrews were clinically and pathologically evaluated for the development and characteristics of EAU immunized with six inter-photoreceptor retinoid-binding proteins (IRBPs). IRBP-specific T-cell proliferation and serum cytokine of tree shrews were evaluated to determine the immune responses. Differentially expressed genes (DEGs) were identified in the eyes of tree shrews with EAU by RNA-sequencing. The disruptive effects of the DEG RGS4 inhibitor CCG 203769 and dihydroartemisinin on the EAU were investigated to evaluate the potential application of tree shrew EAU. Results IRBP1197–1211 and R14 successfully induced chronic EAU with subretinal deposits and retinal damage in the tree shrews. The immunological characteristics presented the predominant infiltration of microglia/macrophages, dendritic cells, and CD4-T-cells into the uvea and retina and pathogenic T helper (Th) 1 and Th17 responses. The subretinal deposits positively expressed amyloid β-protein (Aβ), CD8, and P2Y purinoceptor 12 (P2RY12). The crucial DEGs in R14-induced EAU, such as P2RY2 and adenylate cyclase 4 (ADCY4), were enriched for several pathways, including inflammatory mediator regulation of transient receptor potential (TRP) channels. The upregulated RGS4 in IRBP-induced EAU was associated with mitogen-activated protein kinase (MAPK) activity. RGS4 inhibition and dihydroartemisinin could significantly alleviate the retinal pathological injuries of IRBP1197-1211-induced EAU by decreasing the expression of CD4 T-cells. Conclusion Our study provides a novel chronic EAU in tree shrews elicited by bovine R14 and tree shrew IRBP1197-1211 characterized by retinal degeneration, retinal damage with subretinal Aβ deposits and microglia/macrophage infiltration, and T-cell response, probably by altering important pathways and genes related to bacterial invasion, inflammatory pain, microglial phagocytosis, and lipid and glucose metabolism. The findings advance the knowledge of the pathogenesis and therapeutics of the fovea-involved visual disturbance in human uveitis.
Collapse
Affiliation(s)
- Kaijiao Hu
- Laboratory Animal Center, Chongqing Medical University, Chongqing, China.,Chongqing Engineering Research Center for Rodent Laboratory Animals, Chongqing, China
| | - Longbao Lv
- Laboratory Animal Center, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China
| | - Hui Huang
- Laboratory Animal Center, Chongqing Medical University, Chongqing, China.,Chongqing Engineering Research Center for Rodent Laboratory Animals, Chongqing, China
| | - Guangnian Yin
- Laboratory Animal Center, Chongqing Medical University, Chongqing, China.,Chongqing Engineering Research Center for Rodent Laboratory Animals, Chongqing, China.,Department of Clinical Laboratory, the Second Affiliated Hospital of Army Medical University, Chongqing, China
| | - Jie Gao
- Laboratory Animal Center, Chongqing Medical University, Chongqing, China.,Chongqing Engineering Research Center for Rodent Laboratory Animals, Chongqing, China
| | - Jianping Liu
- Department of Pathology, Chongqing Medical University, Chongqing, China
| | - Yaying Yang
- Department of Pathology, Chongqing Medical University, Chongqing, China
| | - Wenxin Zeng
- Laboratory Animal Center, Chongqing Medical University, Chongqing, China.,Chongqing Engineering Research Center for Rodent Laboratory Animals, Chongqing, China
| | - Yan Chen
- Department of Pathology, Chongqing Medical University, Chongqing, China
| | - Ni Zhang
- The First Affiliated Hospital of Chongqing Medical University, Chongqing Eye Institute, Chongqing, China
| | - Feiyan Zhang
- Laboratory Animal Center, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China
| | - Yuhua Ma
- Laboratory Animal Center, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China
| | - Feilan Chen
- Laboratory Animal Center, Chongqing Medical University, Chongqing, China.,Chongqing Engineering Research Center for Rodent Laboratory Animals, Chongqing, China
| |
Collapse
|